What actually happens with Wegovy after 2 months?

How far through the dose schedule are you at week eight?

Wegovy starts at 0.25mg — a tolerability dose whose job is to settle your digestive system, not to drive significant weight loss. After four weeks that rises to 0.5mg, and four weeks later to 1.0mg. So at the two-month mark, most people are sitting at 0.5mg or 1.0mg, with three further dose increases still ahead before reaching the 2.4mg maintenance level.

That context matters enormously. A lot of people expect month two to look like the results pictured at the end of a clinical trial. It won't, and that's not a sign anything has gone wrong. The drug is still being introduced to your system at doses well below the level that produces the greatest weight reduction. Think of it less as a slow start and more as the manufacturer's deliberately cautious ramp-up, designed to spare you the worst of the gastrointestinal side effects all at once.

Your prescriber owns the titration schedule, it's not something to speed up yourself. If you're uncertain about your current dose or the timeline ahead, that's a question for your clinical team, not a reason to adjust independently.

What weight loss is realistic at the two-month point?

The landmark STEP 1 trial (published in the New England Journal of Medicine) followed adults using semaglutide 2.4mg for 68 weeks alongside lifestyle support. Average weight loss across that full period was around 15%. Month two represents roughly an eighth of that total treatment window, and participants in the trial were still dose-escalating at that stage.

Early responders at week eight might have lost 3–6% of body weight. Some will have lost less, particularly if dose increases were slowed for tolerability. A small number will have lost more. None of those positions is wrong. If you want more detail on what typical progress looks like at this stage, our page on how much weight loss to expect from Wegovy after two months breaks down the numbers honestly. The honest truth is that two months isn't a meaningful deadline for judging whether Wegovy is working, the clinical evidence was gathered over more than a year for good reason.

If you're curious how the picture changes later on, what six months on Wegovy tends to look like is a useful next reference point for setting longer-term expectations.

Are the side effects still bad after two months?

For most people, the worst of the gastrointestinal symptoms (nausea, loose stools, indigestion, fatigue) front-load around dose increases rather than running continuously. By week eight, anyone who has stayed on schedule has already navigated the 0.25mg-to-0.5mg step. Moving to 1.0mg may bring a brief return of symptoms, but they tend to be shorter-lived each time as the body adapts.

The NHS semaglutide page lists the common side effects clearly. Worth noting: nausea that eases with food, small meals and staying upright after eating is expected and manageable. Severe, persistent abdominal pain that radiates to the back is different and needs prompt medical attention, the MHRA has flagged acute pancreatitis as a known, though infrequent, risk with GLP-1 medicines. If you're unsure whether what you're experiencing is normal adjustment or something that needs review, contact your prescriber rather than waiting for your next scheduled check-in.

You can report any suspected side effects directly via the MHRA's Yellow Card scheme.

Should you keep going, or is two months long enough to decide?

Two months is not enough time to draw conclusions about whether Wegovy is working for you. NICE's guidance on semaglutide (TA875) sets the six-month mark on the maintenance dose as the clinical checkpoint, the point at which a prescriber considers whether treatment is delivering sufficient benefit to continue. That's six months at 2.4mg, not six months from the first injection.

There's a common misconception that if weight loss hasn't been dramatic by month two, the medicine isn't going to work. Clinical evidence doesn't support that. Weight loss on semaglutide is cumulative and dose-dependent; the biggest gains typically come after the maintenance dose has been established for several months. For a closer look at how results shift once you move past the early dose increases, our guide to what Wegovy looks like after three months covers the transition in useful detail. Stopping early because month two felt underwhelming is one of the more avoidable reasons people miss out on the full effect. The question of stopping Wegovy at three months covers this in more detail, including what the evidence says about what happens to weight after discontinuation.

If cost is part of the calculation, it's worth reading an honest overview of what Wegovy costs in the UK (including what legitimate pricing actually includes) before making a decision based on short-term affordability. And for a broader look at what the medicine is and how it fits into weight management, our full Wegovy guide covers the clinical background in one place.

If you're thinking about starting treatment, or you're on Wegovy and want a prescriber to review how things are going, you can start a free consultation with our clinical team.